Trial Profile

Study of plasma concentration of Imatinib in Chinese patients with gastrointestinal stromal tumor

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 May 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Imatinib (Primary)
Indications Gastrointestinal stromal tumours
Focus Pharmacokinetics; Therapeutic Use

Most Recent Events

30 Apr 2017 Status changed from not yet recruiting to completed.
22 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
22 Apr 2016 Phase of the study is changed from phase I to phase IV.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com